Buxus hildebrandtii
Buxus hildebrandtii · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Buxus hildebrandtii is a plant species that has garnered scientific interest due to its diverse potential pharmacological properties. Recent investigations have specifically focused on the biological activities of its methanolic extracts. Research indicates that these methanol extracts exhibit significant potential in anticancer applications. Furthermore, the plant has demonstrated measurable effects against various types of gram-positive bacteria. These findings highlight the importance of exploring this species for the development of new therapeutic agents.
- Synonyms
- Buxus Pedicellata · Buxanthus Hildebrandtii · 3 more
- Common names
- Not available
- Family
- Buxaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Buxus hildebrandtii is a distinctive plant species widely recognized by its common name, Самшит Гильденбрандта. This botanical variety belongs to the boxwood family, characterized by its dense and resilient growth habits. Gardeners often seek out this specific cultivar for its unique aesthetic qualities and structural stability in landscaping. Understanding its regional nomenclature is essential for those looking to cultivate it in diverse environments. As a member of its genus, it continues to hold a special place in both scientific study and ornamental horticulture.
Sources: Catalogue of Life (COL)
Synonyms
Buxus hildebrandtii is a botanical subject characterized by a complex web of taxonomic synonyms. This species is frequently identified in historical or alternative literature as Buxanthus hildebrandtii or Buxanthus pedicellatus. Researchers may also encounter it listed under the names Buxus calophylla and Buxus pedicellata. Furthermore, the plant has been associated with the name Garcinia buxifolia in certain botanical records. Navigating these various designations is essential for ensuring accurate identification within scientific studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Buxus hildebrandtii is a distinct botanical species that belongs to the kingdom Plantae. Within this vast kingdom, it is categorized under the class Equisetopsida. It further falls into the order Buxales, which helps scientists understand its evolutionary lineage. This plant is a member of the Buxaceae family, showcasing its specific biological characteristics. Finally, it is classified under the genus Buxus, placing it among its close botanical relatives.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Buxales |
| Family | Buxaceae |
| Genus | Buxus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Buxus hildebrandtii is a specialized plant species with a highly specific geographic range located within Northeast Tropical Africa. Its presence is most notably documented across the diverse landscapes of Ethiopia and Somalia. Beyond the mainland, this species also finds a foothold in the unique environment of Djibouti. Additionally, its distribution extends to the isolated and ecologically distinct island of Socotra. Together, these locations define the limited but significant ecological footprint of this particular shrub.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Buxus hildebrandtii adopts a distinct tree-like growth form that distinguishes it from many other species in its genus. This structural development allows the plant to remain entirely self-supporting as it matures.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Buxus hildebrandtii stands out as a significant plant in the study of Yemeni traditional medicine due to its notable medicinal properties. Researchers evaluated the anticancer potential of various methanol extracts by testing them against five different human cancer cell lines. Among the plants investigated, the methanolic extract of this species exhibited exceptionally high cytotoxicity across lung, bladder, and breast cancer models. Specifically, it demonstrated potent inhibitory effects with IC50 values falling within a highly effective range of 0.29 to 5.54 microg/ml. These findings highlight the plant's promising therapeutic value in the ongoing search for natural anticancer agents.
Compounds
Conditions
Buxus hildebrandtii demonstrates significant medicinal potential through its high toxicity against several human cancer cell lines. Specifically, its methanolic extracts exhibit potent anticancer activity against the 5637 and A-427 lung and bladder carcinoma lines. The plant also shows strong cytotoxic effects against the LCLC-103H and MCF-7 cell lines. Beyond its anticancer properties, the extract displays notable antimicrobial activity against Gram-positive bacteria. These diverse biological activities highlight the plant's effectiveness in treating various cellular and bacterial targets.
Preparations
Buxus hildebrandtii is prepared as methanolic extracts to evaluate its various medicinal properties. These methanol extracts are utilized in research to test for high cytotoxic potency against multiple human cancer cell lines. Furthermore, the plant is processed into methanolic extracts to demonstrate significant antimicrobial activity, particularly against Gram-positive bacteria. These same preparations are also studied for their unique ability to display significant antifungal activity. Finally, the methanol extracts of Buxus hildebrandtii are investigated for their efficacy in inhibiting the influenza virus type A.